Articles

Quick View: Venatorx And Menarini Agreement Will Support Global Access To Antibiotic Cefepime-Taniborbactam

Pharmaceuticals / United States / Thu 11 Jan, 2024

The Latest: On January 9 2024, Venatorx and Menarini announced that they had entered into an agreement for the commercialisation of Venatorx’s investigational drug, cefepime-taniborbactam, an antibiotic being developed for the treatment of complicated urinary tract infections (cUTIs). Under the terms of the agreement, Menarini has obtained

Read More

Economic Slowdown And New AI Regulation In the US Will Pose Short-Term Downside Risks To The Medical Devices Market

Medical Devices / United States / Wed 10 Jan, 2024

Key View

  • Growth in the US medical devices market will slow in 2024, reflecting a challenging macroeconomic environment.
  • New regulation and legislation on artificial intelligence (AI)-enabled medical devices in the US will reduce short-term product approvals but provide long-term benefits to the medical devices market.
  • Strengthening medical
Read More
Download Indicator Summary
 

Thank you. Your download link will be emailed to you shortly.

Download Now
 

Thank you. Your download link will be emailed to you shortly.

Download Now
 

Thank you. Your download link will be emailed to you shortly.

Clearbit Form
 

Thank you. Your download link will be emailed to you shortly.